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A Review of acute bacterial meningitis in childhood 
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ABSTRACT: This paper reviews the epidemiology, pathogenesis and management of acute 
bacterial meningitis in childhood. The epidemiology of this infection has undergone significant 
changes with the implementation of effective immunisation, antibiotic therapy and 
chemoprophylaxis. The reported incidence of bacterial meningitis in children in the Maltese 
Islands is low compared to other countries. A high index of suspicion is required to diagnose the 
onset of bacterial meningitis especially in infants. Third-generation cephalosporins are currently 
the antibiotics of choice for the acute disease. The timely administration of pencillin may be life 
saving in cases of meningococcal septicaemia. Adjuvant therapy such as dexamethasone may 
reduce the occurrence and the severity of sequelae, in particular sensorineural hearing loss. 
Chemoprophylaxis with rifampicin has played an important role in curtailing epidemics of 
meningococcal disease. The Haemophilus influenzae type b (Hib) vaccine has made a significant 
impact on the incidence of H. influenzae meningitis in children. Effective vaccines against 
pneumococci and meningococci (type b) do not yet exist, however ongoing research seeks to 
produce these vaccines in an effort to emulate the successful outcome attained by the Hib vaccine. 
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Introduction 
Bacterial meningitis is a common disorder of the 
central nervous system encountered 111 childhood. 
Unless recognised and treated early, this infective 
condition can result in massive destruction of the central 
nervous system. Moreover, sequelae of bacterial 
menmgltls such as sensorineural hearing loss, 
hydrocephalus and seizures may seriously impair the 
development of the child. 
Incidence 
The real incidence of bacterial meningitiS is not known 
as there is substantial under-reporting 1 In England & 
Wales approximately 1400 cases of bacterial meningitis 
occur in children per year gi ving an incidence of :1.:1 per 
100,000. Approximately two-thirds of these cases occur 
in children under 5 years of age. Until recently a large 
number of cases of bacterial meningitis in children were 
due to Haemophilus influenzae but this has dropped 
dramatically in the UK following the introduction of the 
Haemophilus influenza type b vaccine (Hib) in October 
1992. This drop has in turn led to a relati ve increase in 
the percentage of meningococcal disease 1 A similar 
shift in the causative organisms for bacterial meningitis 
was noted even earlier in Boston, Massachusetts since 
the licensure of Hib vaccine was endorsed in 1987 "­
Varying incidences of bacterial meningitis arc found in 
other parts of the world. Ln the U.S.A. the reponed 
incidence is about 6 per 100,000 per year 3, while in 
Barcelona, Spain an incidence of 24 per 100,000 has 
been recorded cl In a three year study by Carroll & 
CaITolI, a particularly high incidence of 134 cases of 
bacterial meningitis per 100,000 children has been found 
in Vanuatu in the Pacific Islands S Increasing incidence 
of HIV infection may have an il1lportant impact on the 
future incidcnce of bacterial meningitis ('. 
The reported incidence of bacterial meningitis in the 
Maltese Islands is about 1.3 cases per 100,000 per year 7 
Figure I depicts the number of cases of bacterial 
meningitis in children in the Maltese Islands over the last 
10 years 7 Cases of meningococcal septicaem ia during 
this pe riod are also shown 
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Fig 1 - Bacterial Meningitis in children in the 
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many parts of the world. Meningitis due to 
Streptococcus pneumoniae tends to occur in children 
over 5 years of age. A similar microbiological pattern 
for bacterial meningitis is found in the Maltese Islands 
(Figure 2) 7. 
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Fig 2 - Microbiology of bacterial meningitis in children in 
the Maltese Islands (1985 - 95) 
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Other pathogens less commonly causing bacterial 
meningitis include: Staphylococcus, enteric bacteria, 
Group 8 Streptococcus and Listeria. These occur 
mainly in neonates, children with immunodeficiencies or 
following neurosurgical procedures including ventriculo­
peritoneal shunts and head trauma.1. Tuberculous 
meningitis is now a rare occurrence in developed 
countries . 
Pathogenesis 
Most cases of acute bacterial meningitis progress 
through four stages: Initially, infection of the upper 
respiratory tract occurs. This is followed by bacterial 
invasion of the blood stream. If this infection is not 
controlled by the immune system, the blood-borne 
bacteria will then seed the ll1eninges leading to an 
inflall1mation of the meninges and the intracranial 
structures. The brain parenchyma arc inflamed and 
involvement of the blood vessel walls results in 
endothelial cell injury, vessel stenosis and thrombosis; 
secondary ischaemia and infarction may then occur. In 
the acute stage this inflammatory process ll1ay result in 
cerebral oedema' and impaired cerebrospinal fluid flow 
leading to hydrocephalus B. 
Clinical features 
Acute bacterial meningitis occurs when symptoms 
associated with the infect ion evolve rapidl y over I [024 
hours . Clinically, oleicI' chilclren can lm~ sen t with a 
variety of symptoms such as fev e r, genel'al nl,tlaise, 
headache, neck stillness and focal sensory and 1l10tor 
deficits . Sei zures with fever, sOll1etimes temperature 
instability and hypothermia, may be an ill1portant 
presenting feature of bacterial ll1eningitis in infants, and 
it lumbar puncture should be considered 9 
Signs of meningeal irriwtion such as neck stillness. 
Kernig's and l3rudzinski's signs, usuall y found in older 
children and adolescents, arc often absent in yo ung 
infants . Converse ly, a bulging fontanelle and increased 
head circull1ference are cOlllmon signs in this age group. 
Papilloedema is a late s ign occurring in older l'hildren. 
Laboratory investigation 
As soon as meningitis is suspected, basic information 
such as a complete blood count, serum electrolytes, renal 
function and also blood cultures should be obtained. The 
most important investigation is cerebrospinal fluid 
examination. A lumbar puncture is performed in all 
cases of suspected meningitis except in cases where 
papilloedema or focal signs are present, or when the 
child is deteriorating rapidly as 111 cases of 
meningococcal meningitis associated with septicaemia, 
In such cases, lumbar puncture may be omitted and the 
diagnosis based on clinical findings and blood cultures. 
Neuroimaging procedures (CT or MRI scans) may 
exclude space occupying lesion and demonstrate bone 
fractures which may have predisposed to the meningitis . 
Usually bacterial meningitis is strongly suggested if 
the CSF contains a high proportion of 
polymorphonuclear leucocytes. a high protein and a low 
glucose concentration. This is, in general, a different 
picture from meningitis caused by other pathogens. In 
cases of partially treated bacterial meningitis, the results 
obtained may diffe r from the 'typical' picture mentioned 
above. 
Treatment 
Until a few years ago, triple antibiotic therapy using 
Penicillin, Chloramphenicol and Sulphonamides was the 
standard treatment for bacterial meningitis. However, 
with bacteria becoming more resistant to antibiotics, 
third generation cephalosporins like ceftriaxone and 
cefotaxime are now preferred, These antibiotics 
penetrate the meninges effectively and quickly. 
Moreover , the use of third generation cephalosporins in 
acute bacterial meningitis appears to decrease the 
incidence of seq uelae 1 It is standard practice that as 
soon as meningococcal septicaemia (which ll1ay not 
necessaril y be assoc iated with meningitis) is suspected, 
an intravenous or intramuscular injection of Benzyl­
penicillin in high dose should be administered. 
Several s tudies have been carried out in order to find 
other adjunctive therapies that significantly minimise 
sequelae. One such th e rapy is corticoste roids, The 
routine use of steroids with antibiotics in the trcatment or 
bacterial meningitis remains controversial. Some studies 
have shown that adjunctive dexarnethasone therapy 
improves the outcome of bacterial meningitis and 
recommend its use 12.13 In contrast, a multicentre 
p lacebo controlled trial in the USA 14 concluded that 
dexamethasone did not significantly improve aucliologic. 
neurolog ic and developmental outcome in children with 
bacterial men ingiti s. Moreove r, the injudicIOUS use of 
corticosteroids 111 those with acute tuberculosis 
meningitis can result in miliary spread of TB and 
death 15. 
Others 1(, ha ve investigated the possibility of giving 
oral Glycerol and /or IV dex amethasune to patients w ith 
bacterial meningiti s IC) They found that oral glycerol 
prevented neurologic sequelae in infants and children 
with bacterial meningitis more effec tively than 
intravenous de.\:llllethasone. The children who received 
mal glycerol showed less severe or proround bilateral 
hear ing illlpall'lllent than those who did not. 
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Immunisation 
Haemophilus influenza type b vaccination has 
effectively decreased the incidence of H. intluenzae 
meningitis 1.2. This conjugate vaccine is given at the 
time of the standard triple vaccine. Work is currently 
being done on conjugate vaccines against pneumococci 
and meningococci. 
Antibiotic prophylaxis 
Rifampicin tS recommended for prophylaxis 111 
contacts of meningococcal disease to eradicate 
nasopharyngeal carriage and decrease spread of the 
infection. In cases of Groups A and C meningococcal 
strains, the vaccination is recommended to at-risk 
individuals over 2-3 years of age. 
Chemoprophylaxis is no longer recommended for 
contacts of patients with Haemophilus influenzae 
meningitis, in regions where Hib vacination is 
implemented. Rifampicin prophylaxis is still given to all 
household contacts, if there are children under 4 years of 
age who have not been immunised completely or not at 
all. 
No effective antibiotic prophylaxis is available for 
pneumococcal meningitis but Pneumovax can be given 
to contacts over 5 years of age I. 
Sequelae 
The prognosis of bacterial meningitis remains rather 
unsatisfactory with an overall mortality of ten percent I. 
Long-term sequelae of meningitis result from direct 
int1ammatory destruction of brain cells, vascular injury 
or secondary gliosis. Ten percent of survivors have 
sensorineural hearing loss, mainly due to cochlear 
damage. This occurs early on in the course of the 
disease and can lead to profound deafness 10. 
Seven percent of the surviving children have 
intractable epilepsy I . Neurological deficits such as 
hemiparesis, quadriparesis or blindness occur in four 
percent of children following bacterial meningitis 10. 
Others may have attention deficits 11, behavioural and 
leaming difficulties and, less commonly, hydrocephalus. 
Conclusion 
Acute bacterial meningitis is a curable disease and 
sequelae are significantly diminished if early diagnosis is 
made and prompt antibiotic therapy is implemented. 
Chemoprophylaxis is important especially in cases of 
meningococcal disease. Now that Hib vaccination is 
becoming widely available , it is expected that meningitis 
due to Haemophilus intluenzae will continue to decrease. 
Moreove r, the deve lopment of effectIve vaccines against 
pneumococci and meningococci may further decrease 
the incidence of acute bacterial meningitis in children. 
References 
I. 	 Nathavitharana KA. Tarlow MJ. Auvalll'cs in Ireating 
bactcrialmeningitis. Upuate July 1005 ; 60-76. 
2. 	 Loughlin AM, Marchant CD, Lett SM. Thc l'hunging 
epidcmiology of in vas ive bacterial infections III 
Massachusells children, 1084 through 1091. Am J Public 
Health 1995; 85(3)::192-4. 
3. 	 Beneson Abram S (ed). Bacte rial Meningitis in: Control 
of Communicable Diseases in Man. 15th Edition. 
Washington: American Public Health Association, 1000: 
279-286. 
4. 	 Roca J, Campos J, Monso G et al. Meningitis in 
Paediatrics. Clinical and epidemiological study of 1173 
cases. Enferm Infect Microbiol Clin 1992: 10(2):79-88. 
5. 	 Carroll KJ, Can'ol C. A prospective investigation of the 
long-term auditory-neurological sequelae associated with 
bacterial meningitis: a study from Vanuatu. J Trop Meu 
Hyg 1994; 97: 145-50. 
6. 	 Ford H , Wright J. Bacterial meningitis in Swaziland: an 
18 month prospective study of its impact. J Epidemiol 
Community Health 1994: 48:276-80. 
7. 	 Department of Health Information, Malta. 
8. 	 Hathaway WE, Hay WW Jr, Groothuis JR, Paisley JW 
eds. Neurologic and Muscular Disorders. In Current 
Paediatric Diagnosis and Treatment. II th Edition. 
Connecticut: Applcton & Lange, 1993; 22:674-747. 
9. 	 Akpede GO, Abiodun PO, Ambe JP et al. Presenting 
feature s of' bacterial meningitis in young infants . Ann 
Trop Paediatr 1994; 14:245-52. 
10. 	 Pomeroy SL, Holmes SJ, Dodge PR et al. Seizures and 
other neurologic sequelae o f bacteri,tl mcningllb in 
children. N Engl J Med 1990; .12.1(24):1651-7. 
11. 	 Kelly DJ>, Kelly BJ, Jones MI et al. Attention deficits in 
children and adolescents with hearing loss. A survey. 
AmJDisChildl993; 147:7.17-41. 
12. 	 Schaau UB, Lips U, Gnehrn HE e t al. Dexame thasone 
therap y for bacterial meningitis in children. Swiss 
Meningitis Study Group. Lancet 199.1; .142:457-61. 
13. 	 Bhatl SM, Cabellos C. Nadol JB Jr et al. The Impact of 
dexamethasone on hearing loss LI1 experimental 
pneumococcal meningiti s. Paediatr Infect Dis J 1995; 
14:93-6. 
14. 	 Wald ER, Kaplan SL, Mason EO et al. Dexame thasone 
therapy for chiluren with bacterial meningitis. Meningitis 
Study Group. Paed iatrics 1995: 1:21-8. 
15. 	 Davi s LE. Danger of corticosteroid administration in 
meningitis due to misdiagnosed agent. Paediatr Neurol 
1994; 10:33 8-9 . 
16. 	 Kilpi T, Peltola H. Jauhiainen T et al. Oral glycerol and 
intraveno us dexamethsone in preventing neurol ogic and 
audiologic sequelae of childhood bacterial meningitis. 
The Finnish Study Group. Paediatr Infect Dis J 1905; 
14:270-8. 
The copyright of this article belongs to the Editorial Board of the Malta Medical Journal. The Malta 
Medical Journal’s rights in respect of this work are as defined by the Copyright Act (Chapter 415) of 
the Laws of Malta or as modified by any successive legislation. 
Users may access this full-text article and can make use of the information contained in accordance 
with the Copyright Act provided that the author must be properly acknowledged.  Further 
distribution or reproduction in any format is prohibited without the prior permission of the copyright 
holder. 
This article has been reproduced with the authorization of the editor of the Malta Medical Journal 
(Ref. No 000001) 
 
